It’s “I have no evidence of his PED use, but I’m not voting for Jeff Bagwell” season

75 Comments

I guess we’re going to do this again. We’re going to say that Jeff Bagwell, by the fame, by the accomplishments and by the numbers, is worthy of the Hall of Fame. But we’re then going to not vote for him because … I’m not sure why. The first of the season is Jeff Jacobs of the Hartford Courant:

Based on numbers alone, Bagwell deserves to be in the Hall of Fame. That part is easy. He hit .297 with 449 homers, eight 100-RBI seasons and had a .948 OPS as well as a Gold Glove and an MVP Award. Yet because of the sins of his baseball generation, fair or not, Bagwell finds himself in an uncomfortable position.

It’s only uncomfortable because you and others like him put him there, Mr. Jacobs.

If there’s a positive test of PED use, fine. If there is a convincing report that the man used PEDs, fine.  But in Bagwell’s case we have neither right now. All we have are people who believe something based on their gut and guilt by the loosest association. And who will likely have no problem voting for Jim Thome, Frank Thomas and other big-slugging first basemen of the era when their time comes.

And I really can’t believe that no one has a giant problem with this.

Report: Nathan Eovaldi drawing interest from at least nine teams

Nathan Eovaldi
Getty Images
Leave a comment

Former Red Sox right-hander Nathan Eovaldi is up for grabs this offseason, and Nick Cafardo of the Boston Globe says that as many as nine suitors are interested in bringing the righty aboard. While the Red Sox are eager to retain Eovaldi’s services after his lights-out performance during their recent postseason run, they’ll have to contend with the Brewers, Phillies, Braves, White Sox, Padres, Blue Jays, Giants, and Angels — all of whom are reportedly positioned to offer something for the starter this winter.

It wasn’t all smooth sailing for the 28-year-old in 2018, however. After losing his 2017 season to Tommy John surgery, he underwent an additional procedure to remove loose bodies from his right elbow in March and didn’t make his first appearance until the end of May. He was flipped for lefty reliever Jalen Beeks just prior to the trade deadline and finished his season with a combined 6-7 record in 21 starts, a 3.81 ERA, 1.6 BB/9, and 8.2 SO/9 through 111 innings.

Despite his numerous health issues over the last few years, Eovaldi raised his stock in October after becoming a major contributor during the Red Sox’ championship run. He contributed two quality starts in the ALDS and ALCS and returned in Games 1-3 of the World Series with three lights-out performances in relief — including a six-inning effort in the 18-inning marathon that was Game 3.

A frontrunner has yet to emerge for the righty this offseason, but Cafardo points out that the nine teams listed so far might just be the tip of the iceberg. Still, he won’t be the most sought-after starter on the market, as former Diamondbacks southpaw Patrick Corbin is expected to command an even bigger payday following his career-best 6.0-fWAR performance in 2018.